Cargando…
Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand
BACKGROUND: The national Human Papillomavirus (HPV) Immunisation Programme in New Zealand was introduced in 2008, and involves routine vaccination of girls 12–13 years with a catch-up for females aged up to 19 years. The aims of this study were to measure the pre-vaccination prevalence of oncogenic...
Autores principales: | Simonella, Leonardo M, Lewis, Hazel, Smith, Megan, Neal, Harold, Bromhead, Collette, Canfell, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607885/ https://www.ncbi.nlm.nih.gov/pubmed/23452957 http://dx.doi.org/10.1186/1471-2334-13-114 |
Ejemplares similares
-
Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand
por: Kang, Yoon-Jung, et al.
Publicado: (2015) -
Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
por: Lew, Jie-Bin, et al.
Publicado: (2016) -
A survey of population-based utility scores for cervical cancer prevention
por: Simonella, Leonardo, et al.
Publicado: (2014) -
Knowledge, attitudes and awareness of the human papillomavirus among health professionals in New Zealand
por: Sherman, Susan M., et al.
Publicado: (2018) -
Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study
por: Bromhead, Collette, et al.
Publicado: (2021)